ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      -0.34%
      US Tech 100
      17,014.40
      0.91%
      Dow Jones
      37,903.29
      0.23%
      Brent Oil
      84.025
      0.58%
      Bitcoin
      57,890.03
      -0.60%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Theravance Biopharma Inc (TBPH)

      7. Theravance Biopharma Inc (TBPH) News

      TBPH

      Theravance Biopharma (TBPH)

      Theravance Biopharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TBPH
      DateTimeSourceHeadlineSymbolCompany
      04/29/20246:00AMPR Newswire (US)Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:TBPHTheravance Biopharma Inc
      04/10/20246:00AMPR Newswire (US)Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024NASDAQ:TBPHTheravance Biopharma Inc
      02/26/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
      02/26/20244:05PMPR Newswire (US)Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
      02/22/20248:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      02/22/20248:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      02/22/20248:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      02/22/20248:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      02/22/20248:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      02/22/20246:00AMPR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
      02/16/20248:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      02/14/20244:00PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TBPHTheravance Biopharma Inc
      02/14/20246:00AMPR Newswire (US)Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:TBPHTheravance Biopharma Inc
      01/16/20246:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
      01/05/20246:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
      01/05/20246:00AMPR Newswire (US)Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)NASDAQ:TBPHTheravance Biopharma Inc
      12/28/20236:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
      12/26/20236:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      12/26/20236:06PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      12/21/20235:10PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TBPHTheravance Biopharma Inc
      12/21/20235:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
      12/21/20235:00PMPR Newswire (US)Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of DirectorsNASDAQ:TBPHTheravance Biopharma Inc
      12/18/20236:00AMPR Newswire (US)Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare ConferenceNASDAQ:TBPHTheravance Biopharma Inc
      11/22/20236:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      11/22/20236:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      11/22/20236:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      11/22/20236:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      11/16/20236:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
      11/16/20236:00AMPR Newswire (US)Theravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous SystemNASDAQ:TBPHTheravance Biopharma Inc
      11/15/20236:00AMPR Newswire (US)Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:TBPHTheravance Biopharma Inc
       Showing the most relevant articles for your search:NASDAQ:TBPH